Clinicopathological differences exist between CALR- and JAK2-mutated myeloproliferative neoplasms despite a similar molecular landscape: data from targeted next-generation sequencing in the diagnostic laboratory
Crossref DOI link: https://doi.org/10.1007/s00277-017-2937-6
Published Online: 2017-02-04
Published Print: 2017-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Agarwal, Rishu https://orcid.org/0000-0002-6713-0403
Blombery, Piers
McBean, Michelle
Jones, Kate
Fellowes, Andrew
Doig, Ken
Forsyth, Cecily
Westerman, David A.
License valid from 2017-02-04